SynthesisEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025
Leuconostoc as an emerging pathogen in humans: an updated systematic review.
Synthesis in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clinical characteristics and outcomes of adult patients with Leuconostoc species bacteremia: an analysis of 129 consecutive cases.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Chronic granulomatous disease: Clinical, microbial, and genetic findings in 39 Colombian patients.Journal of human immunity · 2026Article
- Sepsis and Liver Abscess Caused byInfectious diseases & clinical microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLeuconostoc belongs to the Lactobacillaceae family and is often mistaken for Enterococcus or Streptococcus. This pathogen is commonly found on plants and vegetables and in dairy products and wine. However, Leuconostoc has recently been recognized as an emerging human pathogen that can cause many types of infections.
aimThe purpose of this study was to systematically review all published literature on Leuconostoc infections and describe the epidemiological and microbiological characteristics, antimicrobial susceptibility, treatments and outcomes of infections in humans.
methodsA systematic review of the literature on Leuconostoc published in the PubMed, Embase, Web of Science, and China National Knowledge Infrastructure (CNKI) databases (as of March 18, 2024) was conducted to obtain epidemiological, clinical, microbiological, therapeutic and outcome data for Leuconostoc infections.
findingsA total of 86 studies involving 126 patients were included in the final analysis. The most common Leuconostoc infections were bloodstream infections, intracranial infections, and infective endocarditis. Comorbidities (neoplasms and gastrointestinal disorders), the use of antibiotics (especially vancomycin), the use of indwelling central venous catheters, and the use of parenteral nutrition were very common among patients. Genetic sequencing and broth microdilution or agar dilution methods were the most reliable methods for the identification of Leuconostoc and antimicrobial susceptibility testing, respectively. Leuconostoc lactis was the most common species identified in clinical practice. The most common treatment regimen was penicillin alone or in combination with aminoglycosides.
conclusionsThe epidemiological characteristics, clinical features, microbiological characteristics, treatments, and outcomes of all published cases of Leuconostoc infection were reviewed in this study, and the findings will contribute to early clinical recognition of infections with this bacterium and improved treatment efficacy.
Indexed as
Identifiers
40965618What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.